Takara Holdings Inc. (2531) - Financial and Strategic SWOT Analysis Review

Published: May 2013

Publisher: GlobalData

Product ref: 172203

Pages: 35

Format: PDF

Delivery: Immediate download

Email details: Forward this to a colleague

Satisfaction guarantee: Yes - details here

Price guarantee: Yes - details here

Price: $ 125.00

Report description

Takara Holdings Inc. (2531) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights:

Takara Holdings Inc. (Takara) is a holding company. It carries out its business through Takara Shuzo Group, Takara Bio Group and Takara Healthcare. The Shuzo group offers alcoholic beverages and seasonings, the Bio group develops biomedicals and the Healthcare group provides health foods. Takara offers shochu, sake, light-alcohol refreshers, wine, whisky, Chinese alcoholic beverages, seasonings, raw alcohol, gene and cell therapies and health foods through its subsidiaries. It operates along with its subsidiaries in Japan, the US, China, and Europe.

Takara Holdings Inc. Key Recent Developments:

Nov 05, 2012 Takara Reports Revenue Of JPY95.7 Billion In H1 Fiscal 2013
Jul 27, 2012 Takara Reports Revenue Of JPY47.3 Billion In Q1 Fiscal 2013
May 09, 2012 Takara Reports Revenue Of JPY198.7 Billion In Fiscal 2012
Jan 30, 2012 Takara Reports Revenue Of JPY153.9 Billion For Nine Months Ended December 31, 2012

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.

Table of contents

Section 1 - About the Company
Takara Holdings Inc. - Key Facts
Takara Holdings Inc. - Key Employees
Takara Holdings Inc. - Key Employee Biographies
Takara Holdings Inc. - Major Products and Services
Takara Holdings Inc. - Pharmaceutical Pipeline Products Data
Takara Holdings Inc., Pipeline Products by Therapy Area
Takara Holdings Inc., Pipeline Products by Development Phase
Takara Holdings Inc. - History
Takara Holdings Inc. - Company Statement
Takara Holdings Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Takara Holdings Inc. - Key Manufacturing Facilities
Section 2 – Company Analysis
Takara Holdings Inc. - Business Description
Takara Holdings Inc. - SWOT Analysis
SWOT Analysis - Overview
Takara Holdings Inc. - Strengths
Strength - Market Position
Strength - Research and Development Activities
Strength - Operational Performance
Takara Holdings Inc. - Weaknesses
Weakness - Revenue Concentration
Takara Holdings Inc. - Opportunities
Opportunity - Emerging Markets
Opportunity - Growing Oncology Market
Takara Holdings Inc. - Threats
Threat - Risks Concerning Dependence on Particular Market
Threat - Uncertain R&D Outcomes
Threat - Intense Competition
Takara Holdings Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Takara Holdings Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Takara Holdings Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Takara Holdings Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Takara Holdings Inc., Recent Developments
Nov 05, 2012: Takara Reports Revenue Of JPY95.7 Billion In H1 Fiscal 2013
Jul 27, 2012: Takara Reports Revenue Of JPY47.3 Billion In Q1 Fiscal 2013
May 09, 2012: Takara Reports Revenue Of JPY198.7 Billion In Fiscal 2012
Jan 30, 2012: Takara Reports Revenue Of JPY153.9 Billion For Nine Months Ended December 31, 2012
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables

Takara Holdings Inc., Key Facts
Takara Holdings Inc., Key Employees
Takara Holdings Inc., Key Employee Biographies
Takara Holdings Inc., Major Products and Services
Takara Holdings Inc., Number of Pipeline Products by Therapy Area
Takara Holdings Inc., Number of Pipeline Products by Development Stage
Takara Holdings Inc., Pipeline Products By Therapy Area and Development Phase
Takara Holdings Inc., History
Takara Holdings Inc., Subsidiaries
Takara Holdings Inc., Key Manufacturing Facilities
Takara Holdings Inc., Key Competitors
Takara Holdings Inc., Ratios based on current share price
Takara Holdings Inc., Annual Ratios
Takara Holdings Inc., Interim Ratios
Takara Holdings Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Takara Holdings Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Takara Holdings Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Takara Holdings Inc., Pipeline Products by Therapy Area
Takara Holdings Inc., Pipeline Products by Development Phase
Takara Holdings Inc., Performance Chart (2009 - 2013)
Takara Holdings Inc., Ratio Charts
Takara Holdings Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Takara Holdings Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 28,

Price: $ 125.00

Related research categories

By company: Takara Holdings, SWOT analysis